In the same study, we found that a large subset of SCLC cell lines is co-dependent on BCL-xL and BCL-2 for their survival, as evident from their high sensitivity to the BCL-xL/2 inhibitor navitoclax (formerly ABT263). This evidence concerns the gene BCL2 and small cell lung carcinoma.